Octapharma Plasma Inc, Omaha, NE – FDA Inspections

Inspection records and compliance data for Octapharma Plasma Inc in Omaha, Nebraska. 6 FDA inspections on record, last inspected September 14, 2021.

Company Profile

This profile covers Octapharma Plasma Inc based in Omaha, Nebraska, United States.

FDA Inspection History

FDA inspections: 6
OAI: 0
VAI: 2
NAI: 4
Form 483s: 0
Warning letters: 0

First inspected August 28, 2009. Last inspected September 14, 2021.

Most cited issue areas

Establish, maintain and follow manufacturing SOPs1 inspection
Personnel capabilities1 inspection
Person performing, test results, interpretation1 inspection

FDA inspections (6)

Date	Result	FDA center(s)	Insp. #
September 14, 2021	NAI	Biologics · Vaccines and Allergenic Products	1153219
March 24, 2017	NAI	Biologics · Blood and Blood Products	1009884
January 8, 2015	VAI	Biologics · Blood and Blood Products	909240
February 6, 2013	NAI	Biologics · Blood and Blood Products	820739
June 7, 2011	VAI	Biologics · Blood and Blood Products	732180
August 28, 2009	NAI	Biologics · Blood and Blood Products	608945

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Methodist Women's Hospital

Lions Eye Bank of Nebraska Inc

Innovative Blood Resources, a Division of New York Blood Center, Inc.

Jay R. Meyer, M.D.

American Red Cross Blood Services

KEDPlasma LLC

Marion, Dr Alan

OrthoPlus Inc

James L. Harper, M.D.

Innovative Blood Resources, Division of New York Blood Center, Inc.